EMA — authorised 29 March 2006
- Status: approved
EMA authorised Rhgaa on 29 March 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 29 March 2006.
Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.